Brief: Adamis Pharmaceuticals To Fund Zimhi Clinical Study With University Of Leiden Expert
28/07/2023 16:38
July 28 (Reuters) - Adamis Pharmaceuticals Corp
ADMP.O :
* ADAMIS PHARMACEUTICALS TO FUND ZIMHI® CLINICAL STUDY WITH
UNIVERSITY OF LEIDEN OPIOID EXPERT
Source text for Eikon: ID:nGNX4zGQsC
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update